Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Secondary Adrenal Insufficiency”

47 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 47 results

Post-approval studies (Phase 4)Study completedNCT02340169
What this trial is testing

Adrenal Suppression and Pharmacokinetics of Topicort® Spray, 0.25% in Pediatric Patients With Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Sun Pharmaceutical Industries, Inc. 129
Very early researchWithdrawnNCT01422707
What this trial is testing

Effect of Short Term Adrenal Suppression on Androgen Overproduction in Overweight Girls With Androgen Excess

Who this might be right for
HyperandrogenemiaObesityPolycystic Ovary Syndrome
University of Virginia
Post-approval studies (Phase 4)Study completedNCT03992261
What this trial is testing

Adrenal Suppression and Absorption Study of Halobetasol Propionate Foam in Subjects 12-17 With Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Mayne Pharma International Pty Ltd 24
Testing effectiveness (Phase 2)Study completedNCT01232543
What this trial is testing

Safety Study Evaluating the Adrenal Suppression Potential of Product 0405 in Pediatric Subjects With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Fougera Pharmaceuticals Inc. 114
Early research (Phase 1)Study completedNCT03645499
What this trial is testing

An Open-Label Study to Assess Safety

Who this might be right for
Plaque Psoriasis
Sun Pharmaceutical Industries, Inc. 88
Post-approval studies (Phase 4)UnknownNCT02282150
What this trial is testing

Modified-release Compared to Conventional Hydrocortisone on Diurnal Fatigue in Secondary Hypoadrenalism

Who this might be right for
Adrenal Insufficiency
Ulla Feldt-Rasmussen 30
Testing effectiveness (Phase 2)Study completedNCT02932878
What this trial is testing

An Open Label, Safety Study to Assess the Potential for Adrenal Suppression

Who this might be right for
Plaque Psoriasis
Sun Pharmaceutical Industries, Inc. 16
Testing effectiveness (Phase 2)Study completedNCT01831960
What this trial is testing

An Evaluation of the Adrenal Suppression Potential and Pharmacokinetic Properties of CB-03-01 Cream in Subjects With Acne Vulgaris

Who this might be right for
Acne Vulgaris
Intrepid Therapeutics, Inc. 42
Testing effectiveness (Phase 2)Study completedNCT02933502
What this trial is testing

Safety Study in Patients With Scalp Psoriasis Suppression Following Maximal Use Treatment With Topical Product

Who this might be right for
Scalp Psoriasis
Sun Pharmaceutical Industries, Inc. 3
Testing effectiveness (Phase 2)Study completedNCT01043393
What this trial is testing

Desoximetasone Spray 0.25%, Hypothalamic Pituitary Adrenal (HPA) Axis Study

Who this might be right for
Psoriasis
Sun Pharmaceutical Industries, Inc. 24
Testing effectiveness (Phase 2)Ended earlyNCT04588688
What this trial is testing

Mifepristone Dynamic Testing for Diagnosis for Central Adrenal Insufficiency

Who this might be right for
Central Adrenal InsufficiencyMifepristone
Tobias Else 3
Large-scale testing (Phase 3)Study completedNCT00575341
What this trial is testing

Dehydroepiandrosterone Substitution in Adolescent and Young Women With Central Adrenal Insufficiency

Who this might be right for
Adrenal Insufficiency
University Hospital Tuebingen 23
Not applicableStudy completedNCT04416217
What this trial is testing

Eosinophilic Esophagitis Steroid Safety Study

Who this might be right for
Eosinophilic Esophagitis
Rabin Medical Center 55
Very early researchStudy completedNCT03709381
What this trial is testing

Effect of Adrenocorticotropic Hormone on Vascular Endothelial Growth Factor Release in Children Study

Who this might be right for
Adrenal InsufficiencyOsteopenia, OsteoporosisSteroid Suppression of ACTH Secretion
Nationwide Children's Hospital 10
Not applicableStudy completedNCT03140761
What this trial is testing

The Prevalence of Secondary Adrenal Insufficiency in Patients With Exacerbation of COPD in Glucocorticoid Treatment Related to Differenct Gene Polymorphisms of the Glucocorticoid Receptor Gene

Who this might be right for
Adrenal Insufficiency
Chronic Obstructive Pulmonary Disease Trial Network, Denmark 78
Testing effectiveness (Phase 2)WithdrawnNCT03298581
What this trial is testing

Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Treatment With Halobetasol Spray in Patients With Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Sun Pharmaceutical Industries Limited
Not applicableStudy completedNCT00575029
What this trial is testing

Adrenal Suppression and Adrenal Recovery Induced by Megestrol Acetate

Who this might be right for
Adrenal Insufficiency
University of Arkansas 7
Testing effectiveness (Phase 2)Study completedNCT02933528
What this trial is testing

Safety Study to Assess the Potential for Adrenal Suppression Following Maximal Use Treatment With DSXS

Who this might be right for
Psoriasis
Sun Pharmaceutical Industries, Inc. 24
Very early researchWithdrawnNCT01422733
What this trial is testing

Effect of Longer-term Adrenal Suppression Using Low Dose Hydrocortisone on Androgen Overproduction

Who this might be right for
HyperandrogenemiaObesityPolycystic Ovary Syndrome
University of Virginia
Testing effectiveness (Phase 2)Study completedNCT01698333
What this trial is testing

Pharmacokinetics of 122-0551 and Its Effects on Adrenal Suppression

Who this might be right for
Plaque Psoriasis
Therapeutics, Inc. 25
Load More Results